APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

G-CSF Biosimilars

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global G-CSF Biosimilars Industry Growth and Trends Forecast to 2032

Report ID 173993620119 December 2025101 pages

Choose your research edition.

Industry ResearchG-CSF Biosimilars Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal G-CSF Biosimilars Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal G-CSF Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal G-CSF Biosimilars Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal G-CSF Biosimilars Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global G-CSF Biosimilars market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for G-CSF Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for G-CSF Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for G-CSF Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of G-CSF Biosimilars include Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Pfizer, GlaxoSmithKline, Bayer and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global G-CSF Biosimilars market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The G-CSF Biosimilars market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global G-CSF Biosimilars market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to G-CSF Biosimilars.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global G-CSF Biosimilars market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

G-CSF Biosimilars Market by Company

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Pfizer

GlaxoSmithKline

Bayer

Amgen

AbbVie

AstraZeneca

Gilead Science

G-CSF Biosimilars Segment by Type

Insulin

Human Growth Hormone

Granulocyte-Colony Stimulating Factor

Interferon

Monoclonal Antibodies

Erythropoietin

G-CSF Biosimilars Segment by Application

Chronic And Autoimmune Diseases

Growth Hormone Deficiencies

Blood Disorders

Oncology Diseases

G-CSF Biosimilars Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-CSF Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of G-CSF Biosimilars and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-CSF Biosimilars.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of G-CSF Biosimilars manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of G-CSF Biosimilars in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Table 2. Major Company of Human Growth Hormone Table 3. Major Company of Granulocyte-Colony Stimulating Factor Table 4. Major Company of Interferon Table 5. Major Company of Monoclonal Antibodies Table 6. Major Company of Erythropoietin Table 7. Global G-CSF Biosimilars Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 9. Global G-CSF Biosimilars Sales Market Share in Volume by Type (2021-2026) Table 10. Global G-CSF Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 11. Global G-CSF Biosimilars Sales Market Share in Value by Type (2021-2026) Table 12. Global G-CSF Biosimilars Price by Type (2021-2026) & (US$/Unit) Table 13. Global G-CSF Biosimilars Sales by Type (2027-2032) & (K Units) Table 14. Global G-CSF Biosimilars Sales Market Share in Volume by Type (2027-2032) Table 15. Global G-CSF Biosimilars Sales by Type (2027-2032) & (US$ Million) Table 16. Global G-CSF Biosimilars Sales Market Share in Value by Type (2027-2032) Table 17. Global G-CSF Biosimilars Price by Type (2027-2032) & (US$/Unit) Table 18. North America G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 19. North America G-CSF Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 20. Europe G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 21. Europe G-CSF Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific G-CSF Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 25. Latin America G-CSF Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa G-CSF Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 28. G-CSF Biosimilars Industry Trends Table 29. G-CSF Biosimilars Industry Drivers Table 30. G-CSF Biosimilars Industry Opportunities and Challenges Table 31. G-CSF Biosimilars Industry Restraints Table 32. Global G-CSF Biosimilars Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global G-CSF Biosimilars Revenue Market Share by Company (2021-2026) Table 34. Global G-CSF Biosimilars Sales by Company (2021-2026) & (K Units) Table 35. Global G-CSF Biosimilars Sales Share by Company (2021-2026) Table 36. Global G-CSF Biosimilars Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global G-CSF Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global G-CSF Biosimilars Major Company Production Sites and Headquarters Table 39. Global G-CSF Biosimilars Company, Product Type & Application Table 40. Global G-CSF Biosimilars Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global G-CSF Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global G-CSF Biosimilars Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global G-CSF Biosimilars Sales by Region (2021-2026) & (K Units) Table 45. Global G-CSF Biosimilars Sales Market Share in Volume by Region (2021-2026) Table 46. Global G-CSF Biosimilars Sales by Region (2021-2026) & (US$ Million) Table 47. Global G-CSF Biosimilars Sales Market Share in Value by Region (2021-2026) Table 48. Global G-CSF Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global G-CSF Biosimilars Sales by Region (2027-2032) & (K Units) Table 50. Global G-CSF Biosimilars Sales Market Share in Volume by Region (2027-2032) Table 51. Global G-CSF Biosimilars Sales by Region (2027-2032) & (US$ Million) Table 52. Global G-CSF Biosimilars Sales Market Share in Value by Region (2027-2032) Table 53. Global G-CSF Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global G-CSF Biosimilars Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 56. Global G-CSF Biosimilars Sales Market Share in Volume by Application (2021-2026) Table 57. Global G-CSF Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 58. Global G-CSF Biosimilars Sales Market Share in Value by Application (2021-2026) Table 59. Global G-CSF Biosimilars Price by Application (2021-2026) & (US$/Unit) Table 60. Global G-CSF Biosimilars Sales by Application (2027-2032) & (K Units) Table 61. Global G-CSF Biosimilars Sales Market Share in Volume by Application (2027-2032) Table 62. Global G-CSF Biosimilars Sales by Application (2027-2032) & (US$ Million) Table 63. Global G-CSF Biosimilars Sales Market Share in Value by Application (2027-2032) Table 64. Global G-CSF Biosimilars Price by Application (2027-2032) & (US$/Unit) Table 65. North America G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 66. North America G-CSF Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 67. Europe G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 68. Europe G-CSF Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific G-CSF Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 72. Latin America G-CSF Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa G-CSF Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sanofi G-CSF Biosimilars Product Portfolio Table 79. Sanofi Recent Development Table 80. Johnson & Johnson Company Information Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Johnson & Johnson G-CSF Biosimilars Product Portfolio Table 84. Johnson & Johnson Recent Development Table 85. Novartis Company Information Table 86. Novartis Business Overview Table 87. Novartis G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Novartis G-CSF Biosimilars Product Portfolio Table 89. Novartis Recent Development Table 90. Merck & Co. Company Information Table 91. Merck & Co. Business Overview Table 92. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merck & Co. G-CSF Biosimilars Product Portfolio Table 94. Merck & Co. Recent Development Table 95. Roche Company Information Table 96. Roche Business Overview Table 97. Roche G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Roche G-CSF Biosimilars Product Portfolio Table 99. Roche Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Pfizer G-CSF Biosimilars Product Portfolio Table 104. Pfizer Recent Development Table 105. GlaxoSmithKline Company Information Table 106. GlaxoSmithKline Business Overview Table 107. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. GlaxoSmithKline G-CSF Biosimilars Product Portfolio Table 109. GlaxoSmithKline Recent Development Table 110. Bayer Company Information Table 111. Bayer Business Overview Table 112. Bayer G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Bayer G-CSF Biosimilars Product Portfolio Table 114. Bayer Recent Development Table 115. Amgen Company Information Table 116. Amgen Business Overview Table 117. Amgen G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Amgen G-CSF Biosimilars Product Portfolio Table 119. Amgen Recent Development Table 120. AbbVie Company Information Table 121. AbbVie Business Overview Table 122. AbbVie G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. AbbVie G-CSF Biosimilars Product Portfolio Table 124. AbbVie Recent Development Table 125. AstraZeneca Company Information Table 126. AstraZeneca Business Overview Table 127. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. AstraZeneca G-CSF Biosimilars Product Portfolio Table 129. AstraZeneca Recent Development Table 130. Gilead Science Company Information Table 131. Gilead Science Business Overview Table 132. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Gilead Science G-CSF Biosimilars Product Portfolio Table 134. Gilead Science Recent Development Table 135. North America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. North America G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 137. North America G-CSF Biosimilars Sales Market Share by Country (2021-2026) Table 138. North America G-CSF Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 139. North America G-CSF Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 140. North America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. North America G-CSF Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 142. North America G-CSF Biosimilars Market Share by Country (2021-2026) Table 143. North America G-CSF Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. North America G-CSF Biosimilars Market Share Forecast by Country (2027-2032) Table 145. Europe G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Europe G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 147. Europe G-CSF Biosimilars Sales Market Share by Country (2021-2026) Table 148. Europe G-CSF Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 149. Europe G-CSF Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 150. Europe G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Europe G-CSF Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 152. Europe G-CSF Biosimilars Market Share by Country (2021-2026) Table 153. Europe G-CSF Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Europe G-CSF Biosimilars Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 157. Asia-Pacific G-CSF Biosimilars Sales Market Share by Country (2021-2026) Table 158. Asia-Pacific G-CSF Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 159. Asia-Pacific G-CSF Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 160. Asia-Pacific G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Asia-Pacific G-CSF Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 162. Asia-Pacific G-CSF Biosimilars Market Share by Country (2021-2026) Table 163. Asia-Pacific G-CSF Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Asia-Pacific G-CSF Biosimilars Market Share Forecast by Country (2027-2032) Table 165. Latin America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Latin America G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 167. Latin America G-CSF Biosimilars Sales Market Share by Country (2021-2026) Table 168. Latin America G-CSF Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 169. Latin America G-CSF Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 170. Latin America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Latin America G-CSF Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 172. Latin America G-CSF Biosimilars Market Share by Country (2021-2026) Table 173. Latin America G-CSF Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Latin America G-CSF Biosimilars Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 177. Middle East and Africa G-CSF Biosimilars Sales Market Share by Country (2021-2026) Table 178. Middle East and Africa G-CSF Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 179. Middle East and Africa G-CSF Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 180. Middle East and Africa G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Middle East and Africa G-CSF Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 182. Middle East and Africa G-CSF Biosimilars Market Share by Country (2021-2026) Table 183. Middle East and Africa G-CSF Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Middle East and Africa G-CSF Biosimilars Market Share Forecast by Country (2027-2032) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. G-CSF Biosimilars Distributors List Table 188. G-CSF Biosimilars Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. G-CSF Biosimilars Image Figure 2. Global G-CSF Biosimilars Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global G-CSF Biosimilars Market Size (2021-2032) & (US$ Million) Figure 4. Global G-CSF Biosimilars Sales (2021-2032) & (K Units) Figure 5. Insulin Image Figure 6. Global Insulin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Human Growth Hormone Image Figure 8. Global Human Growth Hormone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Granulocyte-Colony Stimulating Factor Image Figure 10. Global Granulocyte-Colony Stimulating Factor Sales YoY Growth (2021-2032) & (K Units) Figure 11. Interferon Image Figure 12. Global Interferon Sales YoY Growth (2021-2032) & (K Units) Figure 13. Monoclonal Antibodies Image Figure 14. Global Monoclonal Antibodies Sales YoY Growth (2021-2032) & (K Units) Figure 15. Erythropoietin Image Figure 16. Global Erythropoietin Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global G-CSF Biosimilars Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global G-CSF Biosimilars Market Share by Type 2025 VS 2032 Figure 19. North America G-CSF Biosimilars Sales Market Share in Volume by Type in 2025 Figure 20. North America G-CSF Biosimilars Sales Market Share in Value by Type in 2025 Figure 21. Europe G-CSF Biosimilars Sales Market Share in Volume by Type in 2025 Figure 22. Europe G-CSF Biosimilars Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific G-CSF Biosimilars Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific G-CSF Biosimilars Sales Market Share in Value by Type in 2025 Figure 25. Latin America G-CSF Biosimilars Sales Market Share in Volume by Type in 2025 Figure 26. Latin America G-CSF Biosimilars Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa G-CSF Biosimilars Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa G-CSF Biosimilars Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 G-CSF Biosimilars Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Chronic And Autoimmune Diseases Image Figure 32. Global Chronic And Autoimmune Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 33. Growth Hormone Deficiencies Image Figure 34. Global Growth Hormone Deficiencies Sales YoY Growth (2021-2032) & (K Units) Figure 35. Blood Disorders Image Figure 36. Global Blood Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 37. Oncology Diseases Image Figure 38. Global Oncology Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global G-CSF Biosimilars Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global G-CSF Biosimilars Market Share by Application 2025 VS 2032 Figure 41. North America G-CSF Biosimilars Sales Market Share in Volume by Application in 2025 Figure 42. North America G-CSF Biosimilars Sales Market Share in Value by Application in 2025 Figure 43. Europe G-CSF Biosimilars Sales Market Share in Volume by Application in 2025 Figure 44. Europe G-CSF Biosimilars Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific G-CSF Biosimilars Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific G-CSF Biosimilars Sales Market Share in Value by Application in 2025 Figure 47. Latin America G-CSF Biosimilars Sales Market Share in Volume by Application in 2025 Figure 48. Latin America G-CSF Biosimilars Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa G-CSF Biosimilars Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa G-CSF Biosimilars Sales Market Share in Value by Application in 2025 Figure 51. North America G-CSF Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America G-CSF Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America G-CSF Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe G-CSF Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe G-CSF Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe G-CSF Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific G-CSF Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific G-CSF Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific G-CSF Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America G-CSF Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America G-CSF Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America G-CSF Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa G-CSF Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa G-CSF Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa G-CSF Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. G-CSF Biosimilars Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. G-CSF Biosimilars Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • Human Growth Hormone
  • Granulocyte-Colony Stimulating Factor
  • Interferon
  • Monoclonal Antibodies
  • Erythropoietin
Applications
  • Chronic And Autoimmune Diseases
  • Growth Hormone Deficiencies
  • Blood Disorders
  • Oncology Diseases
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Gilead Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global G-CSF Biosimilars Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global G-CSF Biosimilars Sales Estimates and Forecasts (2021-2032)
  5. 1.3 G-CSF Biosimilars Market by Type
  6. 1.3.1 Insulin
  7. 1.3.2 Human Growth Hormone
  8. 1.3.3 Granulocyte-Colony Stimulating Factor
  9. 1.3.4 Interferon
  10. 1.3.5 Monoclonal Antibodies
  11. 1.3.6 Erythropoietin
  12. 1.4 Global G-CSF Biosimilars Market Size by Type
  13. 1.4.1 Global G-CSF Biosimilars Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global G-CSF Biosimilars Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global G-CSF Biosimilars Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America G-CSF Biosimilars Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe G-CSF Biosimilars Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America G-CSF Biosimilars Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 G-CSF Biosimilars Industry Trends
  2. 2.2 G-CSF Biosimilars Industry Drivers
  3. 2.3 G-CSF Biosimilars Industry Opportunities and Challenges
  4. 2.4 G-CSF Biosimilars Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by G-CSF Biosimilars Revenue (2021-2026)
  2. 3.2 Global Top Players by G-CSF Biosimilars Sales (2021-2026)
  3. 3.3 Global Top Players by G-CSF Biosimilars Price (2021-2026)
  4. 3.4 Global G-CSF Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global G-CSF Biosimilars Major Company Production Sites & Headquarters
  6. 3.6 Global G-CSF Biosimilars Company, Product Type & Application
  7. 3.7 Global G-CSF Biosimilars Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global G-CSF Biosimilars Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 G-CSF Biosimilars Players Market Share by Revenue in 2025
  11. 3.8.3 2025 G-CSF Biosimilars Tier 1, Tier 2, and Tier 3
4 G-CSF Biosimilars Regional Status and Outlook
  1. 4.1 Global G-CSF Biosimilars Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global G-CSF Biosimilars Historic Market Size by Region
  3. 4.2.1 Global G-CSF Biosimilars Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global G-CSF Biosimilars Sales in Value by Region (2021-2026)
  5. 4.2.3 Global G-CSF Biosimilars Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global G-CSF Biosimilars Forecasted Market Size by Region
  7. 4.3.1 Global G-CSF Biosimilars Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global G-CSF Biosimilars Sales in Value by Region (2027-2032)
  9. 4.3.3 Global G-CSF Biosimilars Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 G-CSF Biosimilars by Application
  1. 5.1 G-CSF Biosimilars Market by Application
  2. 5.1.1 Chronic And Autoimmune Diseases
  3. 5.1.2 Growth Hormone Deficiencies
  4. 5.1.3 Blood Disorders
  5. 5.1.4 Oncology Diseases
  6. 5.2 Global G-CSF Biosimilars Market Size by Application
  7. 5.2.1 Global G-CSF Biosimilars Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global G-CSF Biosimilars Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global G-CSF Biosimilars Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America G-CSF Biosimilars Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe G-CSF Biosimilars Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America G-CSF Biosimilars Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi G-CSF Biosimilars Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson G-CSF Biosimilars Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis G-CSF Biosimilars Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck & Co.
  20. 6.4.1 Merck & Co. Company Information
  21. 6.4.2 Merck & Co. Business Overview
  22. 6.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co. G-CSF Biosimilars Product Portfolio
  24. 6.4.5 Merck & Co. Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche G-CSF Biosimilars Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer G-CSF Biosimilars Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline G-CSF Biosimilars Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer G-CSF Biosimilars Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Amgen
  50. 6.9.1 Amgen Company Information
  51. 6.9.2 Amgen Business Overview
  52. 6.9.3 Amgen G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Amgen G-CSF Biosimilars Product Portfolio
  54. 6.9.5 Amgen Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie G-CSF Biosimilars Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca G-CSF Biosimilars Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 Gilead Science
  68. 6.12.1 Gilead Science Company Information
  69. 6.12.2 Gilead Science Business Overview
  70. 6.12.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Gilead Science G-CSF Biosimilars Product Portfolio
  72. 6.12.5 Gilead Science Recent Developments
7 North America by Country
  1. 7.1 North America G-CSF Biosimilars Sales by Country
  2. 7.1.1 North America G-CSF Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America G-CSF Biosimilars Sales by Country (2021-2026)
  4. 7.1.3 North America G-CSF Biosimilars Sales Forecast by Country (2027-2032)
  5. 7.2 North America G-CSF Biosimilars Market Size by Country
  6. 7.2.1 North America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America G-CSF Biosimilars Market Size by Country (2021-2026)
  8. 7.2.3 North America G-CSF Biosimilars Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe G-CSF Biosimilars Sales by Country
  2. 8.1.1 Europe G-CSF Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe G-CSF Biosimilars Sales by Country (2021-2026)
  4. 8.1.3 Europe G-CSF Biosimilars Sales Forecast by Country (2027-2032)
  5. 8.2 Europe G-CSF Biosimilars Market Size by Country
  6. 8.2.1 Europe G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe G-CSF Biosimilars Market Size by Country (2021-2026)
  8. 8.2.3 Europe G-CSF Biosimilars Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific G-CSF Biosimilars Sales by Country
  2. 9.1.1 Asia-Pacific G-CSF Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific G-CSF Biosimilars Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific G-CSF Biosimilars Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific G-CSF Biosimilars Market Size by Country
  6. 9.2.1 Asia-Pacific G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific G-CSF Biosimilars Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific G-CSF Biosimilars Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America G-CSF Biosimilars Sales by Country
  2. 10.1.1 South America G-CSF Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America G-CSF Biosimilars Sales by Country (2021-2026)
  4. 10.1.3 South America G-CSF Biosimilars Sales Forecast by Country (2027-2032)
  5. 10.2 South America G-CSF Biosimilars Market Size by Country
  6. 10.2.1 South America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America G-CSF Biosimilars Market Size by Country (2021-2026)
  8. 10.2.3 South America G-CSF Biosimilars Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa G-CSF Biosimilars Sales by Country
  2. 11.1.1 Middle East and Africa G-CSF Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa G-CSF Biosimilars Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa G-CSF Biosimilars Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa G-CSF Biosimilars Market Size by Country
  6. 11.2.1 Middle East and Africa G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa G-CSF Biosimilars Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa G-CSF Biosimilars Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 G-CSF Biosimilars Value Chain Analysis
  2. 12.1.1 G-CSF Biosimilars Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 G-CSF Biosimilars Production Mode & Process
  7. 12.2 G-CSF Biosimilars Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 G-CSF Biosimilars Distributors
  10. 12.2.3 G-CSF Biosimilars Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst